Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines

被引：18

作者：

Cuschieri, K. ^{[1
]}

Brewster, D. H. ^{[2
]}

Williams, A. R. W. ^{[3
]}

Millan, D. ^{[4
]}

Murray, G. ^{[5
]}

Nicoll, S. ^{[6
]}

Imrie, J. ^{[7
]}

Hardie, A. ^{[1
]}

Graham, C. ^{[8
]}

Cubie, H. A. ^{[1
]}

机构：

[1] Royal Infirm Edinburgh NHS Trust, Specialist Virol Ctr, Scottish HPV Reference Lab, Edinburgh EH16 4SA, Midlothian, Scotland

[2] NHS Natl Serv Scotland, Informat Serv Div, Scottish Canc Registry, Edinburgh EH12 9EB, Midlothian, Scotland

[3] Royal Infirm Edinburgh NHS Trust, Dept Pathol, Edinburgh EH16 4SA, Midlothian, Scotland

[4] Glasgow Royal Infirm, Dept Pathol, Glasgow G4 0SF, Lanark, Scotland

[5] Aberdeen Royal Infirm, Dept Pathol, Aberdeen AB25 2ZN, Scotland

[6] Ninewells Hosp, Dept Pathol, Dundee DD1 9SY, Scotland

[7] Monklands Gen Hosp, Dept Cytopathol, Airdrie ML6 OJS, Scotland

[8] Wellcome Trust Clin Res Facil, Edinburgh EH4 2XU, Midlothian, Scotland

来源：

BRITISH JOURNAL OF CANCER | 2010年 / 102卷 / 05期

关键词：

HPV; genotyping; Scotland; LESIONS;

D O I：

10.1038/sj.bjc.6605556

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

BACKGROUND/METHODS: This study evaluated human papillomavirus (HPV) type prevalence in 370 Scottish invasive cervical cancers (ICCs) using HPV genotyping and HPV mRNA detection. RESULTS: HPV 16 and/or 18 was detected in 72% of cancers overall and in 82% of HPV-positive cancers. HPV 45 and 16 were the most frequently transcribed types. CONCLUSION: A significant reduction in ICC in Scotland should be achieved through the HPV immunisation programme. British Journal of Cancer (2010) 102, 930-932. doi: 10.1038/sj.bjc.6605556 www.bjcancer.com Published online 9 February 2010 (C) 2010 Cancer Research UK

引用

页码：930 / 932

页数：3

共 50 条

[21] Modelling the impact of HPV vaccines on cervical cancer and screening programmes
Garnett, Geoffrey P.
Kim, Jane J.
French, Katherine
Goldie, Sue J.
VACCINE, 2006, 24 : 178 - 186
[22] HPV genotype prevalence in Indian women with cervical disease and estimation of the potential impact of HPV vaccines on prevention of cervical cancer
Nagaraja, Mudhigeti
Narendra, Hulikal
Venkataramana, Banda
Kalawat, Usha
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2023, 43 : 73 - 78
[23] Human papillomavirus (HPV) and HPV associated tumour vaccines
Bubenik, J.
FOLIA BIOLOGICA, 2006, 52 (1-2) : 45 - 46
[24] HPV TYPES DISTRIBUTION IN BULGARIAN PATIENTS WITH INVASIVE CERVICAL CANCER
Kovachev, Stefan
Ganovska, Anita
Gitsova, Stelyana
Kovachev, Miladin
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A62 - A62
[25] Circulating HPV DNA in HPV-associated cancers
Lin, Guigao
Li, Jinming
CLINICA CHIMICA ACTA, 2023, 542
[26] Control of HPV-associated cancers with HPV vaccination
Schiffman, Mark
Saraiya, Mona
LANCET INFECTIOUS DISEASES, 2017, 17 (01): : 6 - 8
[27] Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology
Hampson, Ian N.
VIRUSES-BASEL, 2022, 14 (04):
[28] Cervical cancers avoided by HPV immunisation
Cruickshank, Maggie E.
Grigore, Mihaela
LANCET, 2021, 398 (10316): : 2053 - 2055
[29] HPV vaccines associated with CRPS?
Reactions Weekly, 2014, 1517 (1) : 4 - 4
[30] Single or multiple HPV types in cervical cancer and associated metastases
Ciotti, M
Paba, P
Bonifacio, D
Di Bonito, L
Benedetto, A
Favalli, C
ONCOLOGY REPORTS, 2006, 15 (01) : 143 - 148

← 1 2 3 4 5 →